Dear Colleague,

Will you be at the 2019 BIO International Convention? If so, please join us for a FierceBiotech Executive Breakfast on June 5th from 6:45AM-8:30AM at the Philadelphia Marriott, conveniently located across the street from the Convention Center. Our panel topic this year is Getting Real: The Changing Tide on Real-World Evidence in Drug Development.

Drugmakers are now running real-world studies to find and tap new marketing and payer insights, including long-term safety and outcomes. This new approach requires significant investment and real-world evidence requires the right talent and technology. Our industry expert panelists will address the important questions that companies are facing including where to find that talent & technology and how to deploy it internally or with partners.

This year's speakers include:

• Sandy Leonard / VP, Medical Evidence and Observational Research, AstraZeneca
• Danny Wiederkehr / Senior Director, Global Health Economics and Outcomes Research Team Lead, Pfizer
• Jack Sheehan, RPh, MBA, PhD / Director, Real-World Value and Evidence, Neuroscience, Janssen Scientific Affairs (JSA)
• Additional panelists to be announced

Register now to secure your spot at low early bird rates. You do not have to be registered for the BIO International Convention to attend this breakfast event - all are welcome.

I look forward to seeing you this June in Philadelphia.

Regards,

Rebecca Willumson
Publisher
FierceBiotech